Latest Insider Transactions at P3 Health Partners Inc. (PIII)
This section provides a real-time view of insider transactions for P3 Health Partners Inc. (PIII). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of P3 Health Partners Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of P3 Health Partners Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 24
2024
|
Leavitt Legacy, LLC |
BUY
Open market or private purchase
|
Indirect |
7,974,481
+32.03%
|
-
|
|
Jan 09
2024
|
Sherif Abdou Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
483,868
+23.13%
|
-
|
|
Jan 09
2024
|
Amir Bacchus Chief Medical Officer |
BUY
Other acquisition or disposition
|
Direct |
287,118
+12.53%
|
-
|
|
Dec 31
2023
|
Sherif Abdou Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
483,868
-30.09%
|
$483,868
$1.41 P/Share
|
|
Dec 31
2023
|
Amir Bacchus Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
287,118
-14.32%
|
$287,118
$1.41 P/Share
|
|
Oct 23
2023
|
Gregory N. Kazarian Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
|
Oct 23
2023
|
Lawrence B. Leisure Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
|
Oct 23
2023
|
Gregory D Wasson Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
|
Oct 23
2023
|
Mark Thierer Director |
BUY
Grant, award, or other acquisition
|
Direct |
433,121
+50.0%
|
-
|
|
Oct 23
2023
|
Mary A Tolan Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
|
Oct 23
2023
|
Thomas Edmunds Price Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
|
Oct 23
2023
|
Jeffrey G Park Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,561
+50.0%
|
-
|
|
Sep 13
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$180,000
$2.65 P/Share
|
|
Sep 12
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$180,000
$2.63 P/Share
|
|
Sep 11
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
180,000
+0.18%
|
$360,000
$2.43 P/Share
|
|
Sep 07
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$180,000
$2.06 P/Share
|
|
Sep 06
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$180,000
$2.13 P/Share
|
|
Sep 05
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$180,000
$2.02 P/Share
|
|
Sep 01
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$180,000
$2.07 P/Share
|
|
Aug 31
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$180,000
$2.1 P/Share
|
|
Aug 30
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$90,000
$1.83 P/Share
|
|
Aug 29
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$90,000
$1.7 P/Share
|
|
Aug 28
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$90,000
$1.39 P/Share
|
|
Aug 25
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$90,000
$1.44 P/Share
|
|
Aug 24
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$90,000
$1.5 P/Share
|
|
Aug 04
2023
|
Amir Bacchus Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000,000
+33.28%
|
-
|
|
Aug 04
2023
|
Sherif Abdou Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,500,000
+48.26%
|
-
|
|
Aug 02
2023
|
Atul Kavthekar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
750,000
+49.38%
|
-
|
|
Jun 01
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
21,850
+0.04%
|
$87,400
$4.0 P/Share
|
|
May 31
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
73,969
+0.15%
|
$221,907
$3.98 P/Share
|
|
May 30
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
65,862
+0.13%
|
$197,586
$3.75 P/Share
|
|
May 26
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$270,000
$3.9 P/Share
|
|
May 25
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.18%
|
$360,000
$4.0 P/Share
|
|
May 24
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,422
+0.1%
|
$151,266
$3.93 P/Share
|
|
May 23
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
106,994
+0.22%
|
$320,982
$3.91 P/Share
|
|
May 22
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
73,006
+0.15%
|
$219,018
$3.94 P/Share
|
|
May 19
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.19%
|
$270,000
$3.5 P/Share
|
|
May 18
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.19%
|
$270,000
$3.3 P/Share
|
|
May 17
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.19%
|
$270,000
$3.5 P/Share
|
|
May 16
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.19%
|
$270,000
$3.24 P/Share
|
|
May 15
2023
|
Chicago Pacific Founders Ugp Iii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
90,000
+0.19%
|
$270,000
$3.01 P/Share
|
|
May 15
2023
|
Atul Kavthekar Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
18,868
+50.0%
|
$37,736
$2.65 P/Share
|
|
May 12
2023
|
Sherif Abdou Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
108,225
+50.0%
|
$216,450
$2.63 P/Share
|
|
Apr 06
2023
|
Chicago Pacific Founders Ugp, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,739,120
+4.33%
|
$4,739,120
$1.18 P/Share
|
|
Apr 06
2023
|
Leavitt Legacy, LLC |
BUY
Grant, award, or other acquisition
|
Indirect |
9,838,997
+50.0%
|
-
|
|
Apr 06
2023
|
Amir Bacchus Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
251,298
+50.0%
|
-
|
|
Apr 06
2023
|
Amir Bacchus Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,005,193
+50.0%
|
-
|
|
Jan 28
2022
|
Michael Balkin > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,000
+0.2%
|
$60,000
$4.83 P/Share
|
|
Dec 03
2021
|
Sherif Abdou Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
28,185,982
+50.0%
|
$13,219,225,558
$469.77 P/Share
|
|
Dec 03
2021
|
Amir Bacchus Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
3,758,130
+50.0%
|
$1,409,298,750
$375.81 P/Share
|